| Condensed Cash Flow Statement |
|
| For the Years Ended December 31,
|
|
| 2025
|
| 2024
|
| 2023
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
| $
| (13,416)
|
| $
| (480,019)
|
| $
| 856,536
|
Adjustments to reconcile net(loss) income to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Equity loss (income) of subsidiaries
|
|
| (954,454)
|
|
| 300,348
|
|
| (856,536)
|
Changes in prepayments and other receivables
|
|
| 264,941
|
|
| (39,625)
|
|
| -
|
Net cash used in operating activities
|
|
| (702,929)
|
|
| (219,296)
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Loans to subsidiaries
|
|
| (1,698,802)
|
|
| (31,198)
|
|
| -
|
Net cash used in investing activities
|
|
| (1,698,802)
|
|
| (31,198)
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of shares upon IPO
|
|
| -
|
|
| 5,000,000
|
|
| -
|
Proceeds from issuance of shares pursuant to exercise of over-allotment
|
|
| -
|
|
| 413,940
|
|
| -
|
Payments of initial public offering costs
|
|
| -
|
|
| (1,418,521)
|
|
| -
|
Repayments to subsidiaries
|
|
| -
|
|
| (1,183,531)
|
|
| -
|
Net cash provided by financing activities
|
|
| -
|
|
| 2,811,888
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate change on cash and restricted cash
|
|
| -
|
|
| -
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
Changes in cash and restricted cash
|
|
| (2,401,731)
|
|
| 2,561,394
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
Cash and restricted cash, beginning of year
|
|
| 2,561,394
|
|
| -
|
|
| -
|
|
|
|
|
|
|
|
|
|
|
Cash and restricted cash, end of year
|
| $
| 159,663
|
| $
| 2,561,394
|
| $
| -
|
Cash
|
|
| 159,663
|
|
| 2,057,850
|
|
| -
|
Restricted cash
|
|
| -
|
|
| 503,544
|
|
| -
|
|